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A  substantial  body of evidence has been presented recently that indicates that the 
release of mediators  from rat  mast cells  is closely linked  to changes in phospholipid 
metabolism  (1-3).  Selectively  increased  incorporation  of a2po4  into mast-cell  phos- 
phatidic acid (PA), phosphatidylcholine (PC), and phosphatidylinositol  (PI) has been 
shown  to  occur  after  stimulation  by  anti-IgE,  concanavalin  A,  the  polycationic 
histamine-releasing agent compound 48/80, or the calcium ionophore A23187. Studies 
of the  kinetic  and  dose-response  relationships  (1),  as  well  as  the  pharmacologic 
modulation of these  biochemical and functional  responses  (3), strongly suggest  that 
they are intrinsically related processes. Because 1,2-diacylglycerol (DAG) is a precursor 
for each of these phospholipid  molecules,  a  possible central  role for DAG has been 
postulated  to account  for the stimulated  changes in  mast-cell  lipid  metabolism  (1). 
The  experiments  described  in  this  report  were  designed  to  determine  the  levels  of 
DAG  during  mediator  release  from  mast  cells  and  to  probe  the  metabolic  fate  of 
newly formed DAG. 
Materials  and Methods 
Materials and Their Sources.  Materials were obtained as described previously (1-4), except: 
lipid-poor bovine serum albumin  (BSA)  from Calbiochem-Behring Corp., American Hoechst 
Corp., San  Diego, Calif.)  and  Clostridium perfringens phospholipase C  from Worthington Bio- 
chemical Corp., Freehold, N. J. 2-[ 1-14C]arachidonoyl-phosphatidylcholine was synthesized by 
the method of Robertson and Lands (5). 2-[1-14C]arachidonoyl-DAG was obtained by phos- 
pholipase  C  hydrolysis of labeled  PC.  All organic solvents except  those used  for thin-layer 
chromatography (TLC) were redistilled before use. 
Isolation  and  Purification  of Mast  Cells.  Mast  cells  were  obtained  from  the  thoracic  and 
peritoneal cavities of male Sprague-Dawley (Camm Research Institute, Inc., Wayne, N. J.) rats 
and were purified using a BSA density-gradient method which has been described in detail (6). 
Mast cell  preparations  (at least  95% pure and at least  98% viable as assessed  by trypan blue 
exclusion  [7]) were suspended  in mast  cell  medium with  phosphate  (MCM-PO4)  (150  mM 
NaC1,  3.7  mM  KCI,  1  mM  CaCI2,  5.55  mM  glucose,  5  mM  sodium  phosphate,  2  mM 
piperazine-N-N'-bis(2-ethane sulfonic acid), 1 mg/ml lipid-poor BSA, and 1 U/ml heparin, pH 
6.8) unless  otherwise indicated. 
Labeling Experiments.  Purified mast cells  (3  ×  106 cells/ml) were prelabeled by incubation 
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with [3H]arachidonic acid (10 #Ci/10  ~ cells) for 30 min at 37°C. The labeled cells were washed 
twice, resuspended (1.5  X  10S/ml), and 3  X  105 cells were aliquoted into polypropylene tubes. 
Mast-cell lipids were extracted at varying times after stimulation with compound 48/80 (1 #g/ 
ml final concentration in a  final vol of 0.25  ml)  by the addition of 1.65 ml of chloroform/ 
methanol~0.267  N  HCI  (1:2:0.3). After 30  min at room temperature, insoluble material was 
removed from the extract by centrifugation. The supernates were added to tubes containing 
unlabeled marker lipids (20 #g each of monolein,  1,2-diolein, arachidonic acid, triolein, and 
phosphatidic acid) and after thorough mixing, two phases were obtained by centrifugation and 
the upper, aqueous phase was discarded. The organic phase was dried and the lipids (dissolved 
in 0.05 ml of chloroform) were separated by TLC (hexane/diethylether/acetic acid; 30: 70:1). 
Lipid-containing areas (detected by iodine staining) were cut out of the TLC plate, placed in 
Minivials  (Fisher  Scientific Co.,  Pittsburgh,  Pa.),  and  the  radioactivity assessed  after  the 
addition of Scintiverse (Fisher Scientific Co.). 
Isolation and Quantitation of Mast-Cell DAG.  Cellular lipids were extracted by the addition of 
1.5 ml of chloroform~methanol~12  N  HC1  (50:100:0.33) at varying times after mast cells (106 
cells in  0.4  ml)  were  stimulated by compound  48/80.  Insoluble material was  removed by 
centrifugation after 30 rain at room temperature. After the addition of 0.5 ml chloroform and 
0.5 ml of 0.1  N  HCI and mixing, two phases were obtained by centrifugation. No detectable 
acid-catalyzed hydrolysis of phospholipids to DAG was detected. The lipid residue obtained by 
drying the lower phase was dissolved in 0.10 ml of 5% (vol/vol) ether in hexane and applied to 
a 0.075-ml silicic acid column equilibrated in the same solvent. Contaminating neutral lipids 
were eluted by the addition of two 0.20-ml vol of 12.5% (vol/vol) ether in hexane. The DAG- 
containing fraction was eluted by the addition of two 0.20-ml vol of 50%  (vol/vol) ether in 
hexane. After evaporating the solvent, DAG was quantitated by DAG kinase-catalyzed phos- 
phorylation  as  described  in  detail in  a  separate  communication  (4).  Briefly, DAG  kinase 
(Escherichia coli) in the presence of [y-32p]ATP, catalyzes the formation of [32P]phosphatidic 
acid in linear proportion to the quantity of DAG present from  10 to 1,000 pmol (4). 
Analysis ofDAG Metabolites Formed by Mast Cells.  Unless otherwise indicated, 5 nmol of 2-[ 1- 
14C]araehidonoyl-DAG were dried onto the bottom of 12- ×  75-ram polypropylene tubes. Mast 
cells (10  ~) suspended in 0.10  ml of MCM-PO4  (without  BSA) were added. The tubes were 
brought to 37°C and the reaction initiated by ultrasonic dispersion of the labeled substrate and 
mast cell enzymes (Biosonik microprobe, VWR Scientific, Inc., San Francisco, Calif., 30 W, 5 
s). The ensuing reaction was halted by the addition of 1.8 ml chloroform/methanol/0.1 N HCI 
(0.5:1.0:0.3). After 15 min at room temperature, this extract was separated into two phases and 
the lipids separated by TLC as described above for labeling experiments. 
Analysis  of Data.  All experiments were performed in triplicate and data are presented as 
mean  _  SEM.  Significance was assessed using the independent Student's t test (two-tailed). 
Results 
DAG in Mast Cells.  Mast cells were prelabeled with  [aH]arachidonic acid to label 
the endogenous  lipids that  might  act  as precursors in the production of DAG. The 
data presented in Fig.  1 demonstrate that  stimulation of mast  cells with compound 
48/80 resulted in a very substantial and rapid increase in the amount of labeled DAG. 
No  differences were  noted  within  15  s  after  the addition  of compound  48/80,  but 
significant elevation of labeled DAG was  detected within  1 min  after stimulation. 
The  relatively  small  absolute  label  accumulation  in  DAG  (250-300  cpm)  when 
compared  to  prestimulation  levels of labeled  PI,  PC,  PE,  and  triglyceride  (7,600, 
21,000,  4,800,  and  4,300  cpm  respectively) precluded demonstration  of an  absolute 
loss of label in any of these potential precursor lipids. 
Although  these results suggested  that  levels of DAG increase in stimulated  mast 
cells, the elevated labeling of DAG could have been the result of an increase in the 
specific activity of DAG. To resolve this issue, levels of DAG in mast cells were assayed 
directly. The  absolute  levels of DAG  increased  in  stimulated  mast  cells in  parallel KENNERLY  ET  AL.  BRIEF  DEFINITIVE  REPORT  1041 
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Flo.  1.  Accumulation of DAG  in  stimulated mast  cells.  Mast  cells were stimulated either with 
compound 48/80 (open symbols, I/,tg/ml final concentration) or medium alone (closed symbols) for 
the time indicated before extraction, separation, and quantitation of lipids as described in Methods. 
Data obtained in labeling studies are indicated by open and closed circles while those obtained by 
direct quantitation are  indicated by open  and  closed  triangles. Data  represent  mean  _+  SEM  of 
triplicate values obtained in one of three similar experiments.  Stimulation ratios (+  SEM)  were 
obtained when data  from  all labeling experiments were pooled:  1 min,  3.15  +_  0.64;  5  rain, 2.44 
+  0.36;  for direct quantitation studies:  1 min, 2.54  +  0.17;  3  min, 3.70  +  0.71;  10 min, 3.13  + 
0.14. 
TABLE  I 
Fate of Diacylglycerol in Broken-Cell Preparations of Mast Cells 
Lipid class  Percentage of labeled products 
% 
Fatty acids  43.3  ±  7.2 
Phospholipids  29.2  ±  15.2 
Monoacylglycerol  19.5 ::l: 11.5 
Triglyceride  8.1  ±  2.7 
Labeled DAG was dispersed and  l0  s mast cells broken by sonication. After  15 min at 
37°C,  lipid-soluble products  were obtained  by extraction and  separated  by TIC  as 
described in Methods. The amount of label comigrating with authentic standards was 
determined and the percentage of the contribution of each lipid class to the total quantity 
of newly formed labeled products was calculated for each experiment. Data represent 
mean  ±  SEM of means obtained in three different experiments (total labeled productsi 
542  ±  67 pmol/15 rain per 105 cells). 
with the increase in DAG labeling seen with  [~H]arachidonate-labeled cells (Fig.  1). 
Significantly elevated DAG levels were observed  I, 3, and  10 min after the addition 
of compound 48/80 (stimulation ratios of 2.2, 2.29, and 3.07, respectively; P <0.001). 
Fate of DAG in Mast-Cell Homogenates.  The metabolism of DAG was examined in 
broken-cell preparations of mast cells as described in Methods. The major metabolic 
product obtained from labeled DAG was free arachidonic acid (Table I). Substantial 
formation  of  labeled  triglycerides,  phospholipids,  and  monoacylglycerol  also  was 
detected. Further analysis of free arachidonic acid formation was assessed as illustrated 
in  Fig.  2.  The  data  presented  in  Fig.  2A  demonstrate  that  the  production  of 
unesterified  arachidonate  was  linearly  dependent  upon  the  amount  of  mast-cell 
homogenate present during the incubation.  When mast cells were heated (100°C for 
5 min) before their disruption, no arachidonate was released from labeled DAG (not 
shown).  Fig.  2 B  illustrates  the  rate of free arachidonic  acid  formation under  these 
experimental conditions. The release of free arachidonate was constant for the first 5 
min  (220  pmol/min per  106 mast cells),  declining  steadily thereafter.  Interestingly, 
when  2-[1-14C]arachidonyl-phosphatidylcholine  was  used  as  substrate,  instead  of 400" 
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DAG lipase activity in mast cells. (A) Dispersions of 2-[14C]arachidonoyl-DAG (O) or 2- 
[14C]arachidonoyl-phosphatidylcholine (O)  were incubated for 30 min with  varying quantities of 
sonicated mast cells. Lipid-soluble products were extracted, separated, and radioactivity determined 
as described in Methods. The rate of arachidonate release was calculated  (after subtracting the 
quantity of labeled arachidonic acid produced in the absence of added mast-cell sonicates) using the 
specific activity of the radioactive substrate (1.34 mCi/mmol). Data represent  mean  +  SEM of 
triplicate observations made in one of two similar experiments. (B)  Labeled  DAG was sonicated 
with mast cells and aliquots  (containing  106 cells)  were removed at  the times indicated and the 
lipids extracted immediately as described in Methods. Release of labeled arachidonate was deter- 
mined after TLC separation of lipid classes and expressed as mean ±  SEM of triplicate values. In 
a second experiment, the initial rate of arachidonate release was 773  ±  61 pmol/h per 105 cells. 
labeled DAG derived from this same PC, no release of labeled arachidonic acid was 
detected at any homogenate concentration examined. 
Discussion 
The results of this study demonstrate that DAG levels are significantly elevated in 
stimulated  mast cells.  When  mast cells were prelabeled with  [SH]arachidonic  acid, 
washed, and stimulated, levels of labeled DAG were found to rise ~threefold (Fig.  1) 
coincident with active secretion (8).  Quantitative analysis of mast-cell DAG demon- 
strated  that  whole-cell  levels of DAG  rise  two-  to  threefold  during  secretion  with 
kinetics parallel to those observed in the labeling studies (Fig.  1). 
Because DAG has been found to be fusogenic (i.e., to cause or enhance membrane 
fusion)  (9)  and  is  associated  with  membrane  fusion  in  erythrocytes  (10,  11),  the 
increased levels of DAG in stimulated mast-cell membranes may play a  role in the 
fusion process that leads to the release of preformed mediators during secretion. These 
observations are in accord with the hypothesis (1)  that elevated S~PO4 incorporation 
into PI, PA, and PC in mast cells occurs as a result of enhanced DAG production and 
may in part reflect negative regulation of secretion by reducing DAG levels. 
The origin of this newly formed DAG is  not yet established.  De  novo  synthesis of 
DAG seems unlikely because radiolabeled glucose or glycerol are not acutely incor- 
porated into this newly formed DAG (D. A. Kennerly, B. Tung, and T. J. Sullivan. 
Manuscript  in  preparation.).  The actions of phospholipase C, phosphatidate  phos- 
phohydrolase, or triglyceride lipase on  their respective substrates  appear to be the 
most likely mechanisms of DAG formation. 
The absence of a  rise in  DAG levels within  3-8 s after stimulation  is interesting 
because increased a2PO4  incorporation  into PA is detectable at that time (1).  Early 
PA  formation  may occur  as  a  result  of phospholipase  D  action  on  phospholipids KENNERLY ET AL.  BRIEF DEFINITIVE REPORT  1043 
followed  by  a  secondary  conversion  to  DAG  by  the  action  of a  phosphatidate 
phosphohydrolase. Alternatively, mast-cell DAG kinase may initially remove newly 
formed DAG  (by phosphorylation to  form PA)  until  stimulated  DAG production 
exceeds this enzyme's capacity, thereby resulting in abruptly increased levels of DAG. 
Preliminary data (not shown) demonstrate the existence of a  mast-cell DAG kinase, 
but  information  regarding  the  mast-cell  metabolic  pathways  that  utilize  DAG is 
incomplete. 
Studies of the  fate of 2-[1-a4C]arachidonoyl-DAG in  broken-cell preparations  of 
mast cells demonstrated that  free arachidonate is a  major product of the action of 
mast-cell enzymes on arachidonic acid-containing DAG. This hydrolytic activity was 
time dependent, proportional to the quantity ofsonicated mast-cell suspension present 
(Fig. 2), and was abolished by heating the mast-cell preparations to 100°C, indicating 
that the hydrolysis is probably an enzymatic process. The absence of labeled arachi- 
donate production when labeled phosphatidylcholine was used as substrate (Fig. 2 A) 
indicates that  the lipolytic activity in mast-cell homogenates preferentially cleaved 
fatty acids from DAG and suggests the presence of more DAG-lipase activity than 
phospholipase  A2  activity.  A  systematic  evaluation  of mast-cell  phospholipase  A2 
activity would be valuable to determine the relative importance of these two arachi- 
donate-generating pathways. The ability of mast cells to convert DAG to fatty acid 
and  monoacylglycerol may be of considerable importance in the membrane fusion 
process, because these moieties are more fusogenic than DAG itself (9). 
In the studies of Lewis et al.  (12), A23187-stimulated  mast  cells produced ~200 
pmol of arachidonate products/106 cells over a 30-min period (12). In this study, DAG 
lipase  activity  in  mast-cell  homogenates  was  capable  of hydrolyzing  220  pmol 
arachidonic acid/min per 10  6 cells from DAG. The DAG lipase activity demonstrated 
in these studies would be sufficient to account for the level of arachidonate-metabolite 
formation known to occur. 
Sl.llTlmary 
Purified  rat  peritoneal  mast  cells  stimulated  with  the  polycationic  histamine- 
releasing agent compound 48/80 demonstrated a two- to fourfold increase in cellular 
levels of 1,2-diacylglycerol (DAG) within  1 min as detected by radioactive labeling 
and  direct  quantitation  experiments.  When  2-[1-14C]arachidonoyl-DAG was  incu- 
bated in the presence of mast-cell homogenates, a rapid conversion to free arachidon- 
ate, and to a  lesser extent, to monoacylglycerol, triglyceride, and phospholipid was 
observed. The release of arachidonate was proportional to the amount of broken-cell 
preparation added and the time of incubation, was prevented by preheating mast-cell 
preparations, and did not occur when 1-[1-14C]arachidonoyl-phosphatidylcholine was 
used as substrate, suggesting that the degradation was mediated by an enzyme with 
DAG-lipase activity. Although much work remains to be done to clarify the precise 
role  of DAG  in  mast  cells,  DAG  metabolism  may  be  involved  in  secretion  by 
generating substances which may facilitate membrane fusion and also in arachidonic 
acid-derived mediator formation by liberating esterified arachidonic acid from mast- 
cell lipids.  Taken together, these studies  indicate that  the formation of DAG may 
play a central role in mast-cell function. 
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